Hepatic Glycogen Metabolism in Type 1 Diabetes After Long-Term Near Normoglycemia

  1. Martin G. Bischof1,
  2. Elisabeth Bernroider1,
  3. Martin Krssak1,
  4. Michael Krebs1,
  5. Harald Stingl1,
  6. Peter Nowotny1,
  7. Chunlin Yu2,
  8. Gerald I. Shulman2,
  9. Werner Waldhäusl1 and
  10. Michael Roden1
  1. 1Division of Endocrinology and Metabolism, Department of Internal Medicine III, University of Vienna Medical School, Vienna, Austria
  2. 2Howard Hughes Medical Institute, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut

    Abstract

    We tested the impact of long-term near normoglycemia (HbA1c <7% for >1 year) on glycogen metabolism in seven type 1 diabetic and seven matched nondiabetic subjects after a mixed meal. Glycemic profiles (6.2 ± 0.10 vs. 5.9 ± 0.07 mmol/l; P < 0.05) of diabetic patients were approximated to that of nondiabetic subjects by variable insulin infusion. Rates of hepatic glycogen synthesis and breakdown were calculated from the glycogen concentration time curves between 7:30 p.m. and 8:00 a.m. using in vivo 13C nuclear magnetic resonance spectroscopy. Glucose production was determined with d-[6,6-2H2]glucose, and the hepatic uridine-diphosphate glucose pool was sampled with acetaminophen. Glycogen synthesis and breakdown as well as glucose production were identical in diabetic and healthy subjects: 7.3 ± 0.9 vs. 7.1 ± 0.7, 4.2 ± 0.5 vs. 3.8 ± 0.3, and 8.7 ± 0.5 vs. 8.4 ± 0.7 μmol · kg−1 · min−1, respectively. Although portal vein insulin concentrations were doubled, the flux through the indirect pathway of glycogen synthesis remained higher in type 1 diabetic subjects: ∼70 vs. ∼50%; P < 0.05. In conclusion, combined long- and short-term intensified insulin substitution normalizes rates of hepatic glycogen synthesis but not the contribution of gluconeogenesis to glycogen synthesis in type 1 diabetes.

    Footnotes

    • Address correspondence and reprint requests to Michael Roden, MD, Division of Endocrinology and Metabolism, Department of Internal Medicine III, University of Vienna Medical School, Waehringer Guertel 18-20, A-1090 Vienna, Austria. E-mail: michael.roden{at}akh-wien.ac.at.

      Received for publication 24 July 2001 and accepted in revised form 25 October 2001.

      M.G.B. and E.B. contributed equally to this study.

      CV, coefficient of variation; EGP, endogenous glucose production; FFA, free fatty acid; HPLC, high-performance liquid chromatography; MPE, mol percent enrichment; NMR, nuclear magnetic resonance; PP-1, protein phosphorylase-1; RIA, radioimmunoassay.

    « Previous | Next Article »Table of Contents